Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipase B domain-containing protein 1 (PLBD1) is a human gene encoding a protein of the phospholipase B-like family. PLBD1 is predicted to possess phospholipase activity, potentially participating in phospholipid catabolism and possibly acting as an amidase or peptidase, but its true catalytic function and physiological substrate remain uncharacterized[1][5][6]. It likely localizes to the extracellular space and/or lysosome, indicating a possible role in lipid processing or turnover[1][6]. PLBD1 has a conserved structural fold shared with other NTN hydrolases, but very limited functional annotation; its loss may theoretically lead to lysosomal storage issues but no such phenotype is documented. There are no drugs, diagnostic tests, or therapies known to target PLBD1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipase B domain-containing protein 1 (PLBD1).